Skip to main content

MoneyWorks4Me

Parmax Pharma gets nod for plant expansion for manufacturing of API products

20 Jun 2018 Evaluate

Parmax Pharma has received an approval for expansion of plant for manufacturing of API products under Goods Manufacturing Practices. The Board of Directors at their meeting held on June 17, 2018, approved the same.

Parmax Pharma deals in all kinds of drug and drugs used in pharmaceutical, medicinal biological immunological, contraceptive and therapeutim preparations, substance materials and articles of all classes and description.

Peers
Company Name CMP
Sun Pharma. Inds. 1885.10
Dr. Reddys Labs. 1390.50
Cipla 1414.95
Lupin 2010.00
Zydus Lifesciences 1195.05
View more..